Kyverna on track to complete miv-cel filing in stiff person syndrome this quarter, CEO says at Meeting on the Mesa
Warner Biddle told Cell & Gene Meeting on the Mesa that Kyverna expects to complete its rolling BLA for miv-cel in stiff person syndrome in Q4 2026, and set out one-year data in SPS and myasthenia gravis and plans in progressive MS.
